1. In vitro pharmacological profile of the novel 5-HT1D receptor agonist, MK-462;Beer;Cephalagia.,1995
2. Rizatriptan vs sumatriptan in the acute treatment of migraine;Visser;Arch Neurol Chicago,1996
3. Placebo-controlled, double-blind study of rizatriptan in multiple attacks of acute migraine;Kramer;Neurology,1997
4. Rizatriptan (MK-0462) for the acute treatment of migraine and migraine recurrence;Block;Neurology,1997
5. Initial human experience with MK-462 (rizatriptan): a novel 5-HT-1D agonst;Sciberras;Br J Clin Pharmacol.,1997